FDA Inspection 1266193 — Advanced Reproductive Medicine & Gynecology Of Hawaii, Inc.
The FDA completed an inspection of Advanced Reproductive Medicine & Gynecology Of Hawaii, Inc. on Mar 25, 2025 in Honolulu, HI. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 25, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Honolulu, HI (United States)